Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 2 5Phase 1/2 3Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Genitourinary 1Dermatologic 1

Conditions

Glioblastoma 2Neoplasms 1Melanoma 1Glioma 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

pembrolizumab 409Cyclophosphamide 398Carboplatin 307Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 209Bevacizumab 207fludarabine 195Docetaxel 186Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 121Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Diet, Ketogenic × Clear all
NCT06896552 2025-03-26

Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.

Rabin Medical Center

Phase 1/2 Not yet recruiting
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Neoplasms

NCT02046187 2021-06-16

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

St. Joseph's Hospital and Medical Center, Phoenix

Phase 1/2 Terminated
14 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT02939378 2016-10-20

KGDinrGBM

Beijing Tiantan Hospital

Phase 1/2 Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡